| Source publication date | (updated 2026-04-13) |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Testosterone and hormone clinic or telehealth website |
| Population | Women |
| Source | 1st Optimal |
| URL | 1stoptimal.com/testosterone-therapy-side-effects-women (opens in a new tab) |
Specific Claim Evaluated
Testosterone increases bone mineral density, prevents visceral abdominal fat storage and produces profound improvements in energy and stamina in women, with uncited improvement rates of 87% and 92%.
Primary Research Supporting or Contradicting the Claim
The global consensus statement found insufficient evidence to support testosterone use in women for bone health, body composition, energy or well-being (Davis et al., 2019). A meta-analysis of randomized trials found benefit only for sexual function and an increase in weight with testosterone (Islam et al., 2019).
Corrected Evidence-Based Interpretation
In women, testosterone has evidence of benefit only for postmenopausal hypoactive sexual desire disorder. Effects on bone density, visceral fat and energy have not been established in randomized trials.
Rationale for Grade
The page states bone, fat and energy benefits as established facts and supports them with response rates that have no cited source. These claims are not supported by randomized evidence, and the weight finding in the meta-analysis runs in the opposite direction to the fat-loss claim.
References
- Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. PMID
Supporting excerpt: "The only evidence-based indication for testosterone for women is for HSDD." - Islam RM, Bell RJ, Green S, Page MJ, Davis SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019;7(10):754-766. PMID
Supporting excerpt: "Testosterone is effective for postmenopausal women with low sexual desire causing distress"